Abstract:Despite the extensive genetic heterogeneity of Hirschsprung disease (HSCR; congenital colonic aganglionosis) 72% of patients harbor pathogenic variants in 10 genes that form a gene regulatory network (GRN) controlling the development of the enteric nervous system (ENS). Among these genes, the receptor tyrosine kinase gene RET is the most significant contributor, accounting for pathogenic variants in 12%-50% of patients depending on phenotype. RET plays a critical role in the proliferation and migration of ENS precursors, and defects in these processes lead to HSCR. However, despite the gene's importance in HSCR, the functional consequences of RET pathogenic variants and their mechanism of disease remain poorly understood. To address this, we investigated the proliferative and migratory phenotypes in a RET-dependent neural crest-derived cell line harboring one of five missense (L56M, E178Q, Y791F, S922Y, F998L) or three nonsense (Y204X, R770X, Y981X) pathogenic heterozygous variants. Using a combination of cDNA-based and CRISPR-based PRIME editing coupled with quantitative proliferation and migration assays, we detected significant losses in cell proliferation and migration in three missense (E178Q, S922Y, F998L) and all nonsense variants. Our data suggests that the Y791F variant, whose pathogenicity has been debated, is likely not pathogenic. Importantly, the severity of migration loss did not consistently correlate with proliferation defects, and the phenotypic severity of nonsense variants was independent of their position within the RET protein. This study highlights the necessity and feasibility of targeted functional assays to accurately assess the pathogenicity of HSCR-associated variants, rather than relying solely on machine learning predictions, which could themselves be refined by incorporating such functional data.

Non-syndromic Hirschsprung's disease as a result of a RET gene variant

Hirschsprung disease: Insights on genes, penetrance, and prenatal diagnosis

Mutation of RET Gene in Chinese Patients with Hirschsprung’s Disease

Genetic Analysis of RET , EDNRB , and EDN3 Genes and Three SNPs in MCS + 9.7 in Chinese Patients with Isolated Hirschsprung Disease

Mutation of the RET Proto-Oncogene in Hirschsprung^s Disease

Sequence Characterization of RET in 117 Chinese Hirschsprung Disease Families Identifies a Large Burden of De Novo and Parental Mosaic Mutations

[The Mutation Character of the RET Proto-Oncogene in Chinese Patients with Hirschsprung's Disease].

Comprehensive characterization of the genetic landscape of familial Hirschsprung's disease

Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population.

A Single RET Mutation in Hirschsprung Disease Induces Intestinal Aganglionosis Via a Dominant-Negative Mechanism

Genome-wide association study of Hirschsprung disease detects a novel low-frequency variant at the RET locus

RET somatic mutations are underrecognized in Hirschsprung disease

[Analysis of RECQL4 Gene Variant in a Child with Rothmund-Thomson Syndrome].

Genetic Variants in RET and Risk of Hirschsprung's Disease in Southeastern Chinese: a Haplotype-Based Analysis

Polymerase Chain Reaction-Single Strand Conformational Polymorphism Analysis of Rearranged During Transfection Proto-Oncogene in Chinese Familial Hirschsprung's Disease.

Variability in proliferative and migratory defects in Hirschsprung disease-associated RET pathogenic variants

The interplay of common genetic variants NRG1 rs2439302 and RET rs2435357 increases the risk of developing Hirschsprung's disease

Variability in proliferative and migratory defects in Hirschsprung disease-associated pathogenic variants

Whole genome sequencing reveals epistasis effects within RET for Hirschsprung disease

High incidence of EDNRB gene mutation in seven southern Chinese familial cases with Hirschsprung's disease

The Ret(C620R) mutation affects renal and enteric development in a mouse model of Hirschsprung's disease